88IV - Public company info - Luye Pharma Group Ltd.

Input the stock code or the company name

Luye Pharma Group Ltd., 02186.HK - Cash Flow	2019-12	2018-12	2017-12	2016-12	2015-12	2014-12	2013-12	2012-12
Net Cash Flow from Operating Activities	2,108,501	1,382,156	1,211,419	753,301	519,767	462,801	543,989	257,963
Net Cash Flow from Return on Investments & Servicing of Finance	-473,499	-354,201	-245,057	-61,115	-9,539	-25,835	-35,510	-30,362
Interest Received	90,012	58,048	24,303	78,821	9,000	22,099	3,030	3,858
Interest Paid	-187,013	-157,717	-51,801	-29,085	-13,971	-40,321	-26,360	-34,220
Dividend Received	911	40,389	352	693	0	0	0	0
Dividend Paid	-377,409	-294,921	-217,911	-111,544	-4,568	-7,613	-12,180	0
Others	0	0	0	0	0	0	0	0
Taxes (Paid) / Refunded	-176,591	-178,852	-195,516	-132,188	-111,088	-103,384	-78,003	-70,841
Net Cash Flow from Investing Activities	-2,782,463	-3,096,185	-768,351	-1,914,409	231,318	-3,000,886	-557,406	-138,988
Additions to Fixed Assets	-970,387	-728,165	-507,322	-263,411	-204,107	-268,836	-265,016	-146,240
Disposal of Fixed Assets	256	2,725	834	110	971	25,162	642	1,677
Increase in Investments	-3,379,477	-3,598,681	-4,611,400	-6,228,489	-5,138,720	-1,840,465	-10,000	-3,000
Decrease in Investments	3,462,740	3,325,000	4,466,668	4,511,806	5,655,080	25,892	0	0
Net Cash Flow with Related Parties	2,864	0	0	0	0	0	0	0
Others	-1,898,459	-2,097,064	-117,131	65,575	-81,906	-942,639	-283,032	8,575
Net Cash Flow before Financing Activities	-1,324,052	-2,247,082	2,495	-1,354,411	630,458	-2,667,304	-126,930	17,772
Net Cash Flow from Financing Activities	1,984,165	2,699,567	950,488	931,557	55,878	2,665,425	99,500	91,517
New Loans	6,805,064	9,219,870	3,866,794	3,404,215	1,491,471	1,747,242	1,298,436	824,338
Loans Repayment	-6,756,017	-5,943,084	-2,629,550	-2,282,817	-1,294,293	-2,187,013	-1,023,915	-809,366
Fixed Income/Debt Instruments	0	0	0	0	0	0	0	0
Repayment of Fixed Income/Debt Instruments	0	0	0	0	0	0	0	0
Equity Financing	2,041,127	0	0	0	0	3,054,926	0	0
Net Cash Flow with Related Parties	2,864	0	0	0	0	0	0	0
Others	-108,873	-577,219	-286,756	-189,841	-141,300	50,270	-175,021	76,545
Increase(Decrease) in Cash & Cash Equivalents	660,113	452,485	952,983	-422,854	686,336	-1,879	-27,430	109,289
Cash & Cash Equivalents at Beginning of Year	1,672,865	1,265,872	-84,886	843,674	151,863	333,150	364,031	251,501
Net Cash Flow due to Change in Exchange Rate/Others	-7,532	-45,492	397,775	-23,045	5,475	592	-3,451	3,241
Cash & Cash Equivalents at End of Year	2,325,446	1,672,865	1,265,872	397,775	843,674	331,863	333,150	364,031
Currency	Renminbi	Renminbi	Renminbi	Renminbi	Renminbi	Renminbi	Renminbi	Renminbi
Unit
Auditor's Opinion	1	1	1	1	1	1	0	0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

88iv | Home | Login

Mobile | Full

Suntek Computer Systems Limited.

Public company info - Luye Pharma Group Ltd. , 02186.HK